Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WALGREEN COMPANY via WALGREEN COMPANY
2024 · first_quarter · Q1
H.R. 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via WALGREEN COMPANY
2023 · fourth_quarter · Q4
Source: Senate LDA
Relating to a national emergency declared by the President on March 13, 2020.
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 7213 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. H.J. Res. 7 - The Covid-19 National Emergency: Issues related to the public health emergency. H.R.1613 - Drug Price Transparency in Medicaid Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. S. 127 - Pharmacy Benefit Manager Transparency Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. Clinical Trial Diversity: Issues related to access to pharmacist services.
Drug Price Transparency in Medicaid Act of 2023
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 7213 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. H.J. Res. 7 - The Covid-19 National Emergency: Issues related to the public health emergency. H.R.1613 - Drug Price Transparency in Medicaid Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. S. 127 - Pharmacy Benefit Manager Transparency Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. Clinical Trial Diversity: Issues related to access to pharmacist services.
H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.
H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.
H.R. 7213 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. H.J. Res. 7 - The Covid-19 National Emergency: Issues related to the public health emergency. H.R.1613 - Drug Price Transparency in Medicaid Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. S. 127 - Pharmacy Benefit Manager Transparency Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. Clinical Trial Diversity: Issues related to access to pharmacist services.
Pharmacy Benefit Manager Transparency Act of 2023
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 7213 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. H.J. Res. 7 - The Covid-19 National Emergency: Issues related to the public health emergency. H.R.1613 - Drug Price Transparency in Medicaid Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. S. 127 - Pharmacy Benefit Manager Transparency Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. Clinical Trial Diversity: Issues related to access to pharmacist services.
H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.
H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 7213 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. Clinical Trial Diversity: Issues related to access to pharmacist services.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909; issues related to direct and indirect remuneration fees in Medicare. H.R. 7213 Equitable Community Access to Pharmacist Services Act; issues related to access to pharmacist services.
To require online marketplaces to verify certain information regarding high-volume third party sellers of consumer products on such online marketplaces and to disclose to consumers certain contact and other information regarding such high-volume third party sellers.
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
To require online marketplaces to verify certain information regarding high-volume third party sellers of consumer products on such online marketplaces and to disclose to consumers certain contact and other information regarding such high-volume third party sellers.
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
To require online marketplaces to verify certain information regarding high-volume third party sellers of consumer products on such online marketplaces and to disclose to consumers certain contact and other information regarding such high-volume third party sellers.
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
To require online marketplaces to verify certain information regarding high-volume third party sellers of consumer products on such online marketplaces and to disclose to consumers certain contact and other information regarding such high-volume third party sellers.
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909; issues related to direct and indirect remuneration fees in Medicare. H.R. 7213 Equitable Community Access to Pharmacist Services Act; issues related to access to pharmacist services.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 7213 Equitable Community Access to Pharmacist Services Act; issues related to access to pharmacist services.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 7213 Equitable Community Access to Pharmacist Services Act; issues related to access to pharmacist services. H.R. 7845 NIH Clinical Trial Diversity Act of 2022; issues related to access to pharmacist services.
Issues related to pharmacy provider status. H.R. 7213 Equitable Community Access to Pharmacist Services Act; issues related to access to pharmacist services. H.R. 7845 NIH Clinical Trial Diversity Act of 2022; issues related to access to pharmacist services.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909; issues related to direct and indirect remuneration fees in Medicare. H.R. 7213 Equitable Community Access to Pharmacist Services Act; issues related to access to pharmacist services.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
Issues related to pharmacies and pharmacists, and Medicare reimbursement; Issues regarding Section 965 - Treatment of Deferred Foreign Income, and other tax issues. Issues related to corporate tax rate and other international tax provisions in Build Back Better Act (H.R.5376).
To require online marketplaces to verify certain information regarding high-volume third party sellers of consumer products on such online marketplaces and to disclose to consumers certain contact and other information regarding such high-volume third party sellers.
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
Pharmacy DIR Reform To Reduce Senior Drug Costs Act
Client: WALGREEN COMPANY · Firm: WALGREEN COMPANY
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
S. 936: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
S. 936: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
S. 936: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via WALGREEN COMPANY
2023 · third_quarter · Q3
H.R. 7213/S. 2477- Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. H.R. 2503/S. 1701 - NIH Clinical Trial Diversity: Issues related to NIH funding for programs to increase diversity in clinical trials.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via WALGREEN COMPANY
2023 · second_quarter · Q2
H.R. 7213 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. Clinical Trial Diversity: Issues related to access to pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via WALGREEN COMPANY
2023 · first_quarter · Q1
H.R. 7213 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. H.J. Res. 7 - The Covid-19 National Emergency: Issues related to the public health emergency. H.R.1613 - Drug Price Transparency in Medicaid Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. S. 127 - Pharmacy Benefit Manager Transparency Act of 2023: Issues related to Pharmacy Benefit Manager (PBM) reform. Public Law: 109-148 - Public Readiness and Emergency Preparedness Act (PREP Act): Issues related to COVID testing and vaccinations. Clinical Trial Diversity: Issues related to access to pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via WALGREEN COMPANY
2022 · fourth_quarter · Q4
Issues related to pharmacy provider status. H.R. 7213 Equitable Community Access to Pharmacist Services Act; issues related to access to pharmacist services. H.R. 7845 NIH Clinical Trial Diversity Act of 2022; issues related to access to pharmacist services.
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via WALGREEN COMPANY
2022 · third_quarter · Q3
Issues related to pharmacy provider status. H.R. 7213 Equitable Community Access to Pharmacist Services Act; issues related to access to pharmacist services.
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via WALGREEN COMPANY
2022 · third_quarter · RA
Issues relating to retail pharmacy.
Issues relating to retail pharmacy.
Issues relating to retail pharmacy.
WALGREEN COMPANY via WALGREEN COMPANY
2022 · second_quarter · Q2
Issues related to pharmacy provider status. H.R. 3554 / S. 1909; issues related to direct and indirect remuneration fees in Medicare. H.R. 7213 Equitable Community Access to Pharmacist Services Act; issues related to access to pharmacist services.
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via WALGREEN COMPANY
2022 · first_quarter · Q1
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via WALGREEN COMPANY
2021 · fourth_quarter · Q4
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Issues related to pharmacies and pharmacists, and Medicare reimbursement; Issues regarding Section 965 - Treatment of Deferred Foreign Income, and other tax issues. Issues related to corporate tax rate and other international tax provisions in Build Back Better Act (H.R.5376).
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
WALGREEN COMPANY via WALGREEN COMPANY
2021 · third_quarter · Q3
S. 936: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
Issues related to pharmacies and pharmacists, and Medicare reimbursement; Issues regarding Section 965 - Treatment of Deferred Foreign Income, and other tax issues. Issues related to corporate tax rate and other tax provisions in The American Jobs Plan.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN COMPANY via WALGREEN COMPANY
2021 · second_quarter · Q2
S. 936: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
Issues related to pharmacies and pharmacists, and Medicare reimbursement; Issues regarding Section 965 - Treatment of Deferred Foreign Income, and other tax issues. Issues related to corporate tax rate and other tax provisions in The American Jobs Plan.
WALGREEN COMPANY via WALGREEN COMPANY
2021 · first_quarter · Q1
S. 936: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
Issues related to pharmacy provider status. Issues related to direct and indirect remuneration fees in Medicare.
Issues related to pharmacies and pharmacists, and Medicare reimbursement; Issues regarding Section 965 - Treatment of Deferred Foreign Income, and other tax issues. Issues related to corporate tax rate and other tax provisions in The American Jobs Plan.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to retail pharmacy.
Issues relating to retail pharmacy.
Issues relating to retail pharmacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE